Daniel Offen

This inventor holds 23 USPTO granted patents and 20 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in CNS Disease Treatment. Top assignees: Tel Aviv University, Brainstorm Cell Therapeutics Ltd., Yeda Research and Develpment & Co. Ltd. Active years: 2002-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Offen. Retrieved from https://idiyas.com/inventor/daniel-offen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 20)

% Patents Active = 87.0

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 10 (Patent Applications = 22)

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 81(Granted Patents)

Location History:

Há Roe, IL (2002)
Kfar Haroeh, IL (2017)
Kfar Ha'Roe, IL (2002 - 2019)
Tel Aviv, IL (2018 - 2023)

Company Filing History:

Brainstorm Cell Therapeutics Ltd.

patents

2 out of 1,168

Yeda Research and Develpment & Co. Ltd

patents

4. 1 out of 1

Brainstorm Ceil Therapeutics Ltd.

patent

5. 1 out of 1,004

Technion Research & Development Foundation Ltd

patents

6. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2023

Loading Chart...

Areas of Expertise:

CNS Diseases

Mesenchymal Stem Cells

Neurodegenerative Diseases

Neurotrophic Factors

Peptides

Cell Therapy

Oxidative Stress

Brain Injuries

Exosomes

Aggregation-Prone Proteins

Isolated Cells

Combination Treatment

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11648260 - Vesicles comprising a PTEN inhibitor and uses of same (2023-05-16),

2. 11185572 - Mesenchymal stem cells for the treatment of CNS diseases (2021-11-30),

3. 11129852 - Mesenchymal cell-derived exosomes to treat neurological disorders (2021-09-28),

4. 11104651 - PERK inhibitors and uses thereof in treating diseases associated with aggregation-prone proteins (2021-08-31),

5. 10869899 - Isolated cells and populations comprising same for the treatment of CNS diseases (2020-12-22),

6. 10744162 - Genetically modified muscle cells which express neurotrophic factors (2020-08-18),

7. 10723706 - Perk inhibitors and uses thereof in treating diseases associated with aggregation-prone proteins (2020-07-28),

8. 10220077 - Combination treatment for amyotrophic lateral sclerosis (ALS) (2019-03-05),

9. 10052363 - Mesenchymal stem cells for the treatment of CNS diseases (2018-08-21),

10. 10040836 - Peptides for the treatment of neurodegenerative diseases (2018-08-07),

11. 9879225 - Isolated cells and populations comprising same for the treatment of CNS diseases (2018-01-30),

12. 9717761 - Stem cell-derived neural cells for cell therapy in neurological disorders (2017-08-01),

13. 9598478 - Peptides for the treatment of neurodegenerative diseases (2017-03-21),

14. 9474787 - Mesenchymal stem cells for the treatment of CNS diseases (2016-10-25),

15. 9365828 - Genetically modified muscle cells which express neurotrophic factors (2016-06-14),

Title: The Innovative Journey of Daniel Offen

Introduction: Daniel Offen, a pioneering inventor hailing from Kfar HaRoe, Israel, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Daniel Offen's latest patents include a cutting-edge virtual reality device that revolutionizes the gaming industry, a smart home automation system that enhances convenience and security, and a sustainable energy solution for urban environments.

Career Highlights: With a career spanning over two decades, Daniel Offen has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its impact on various industries.

Collaborations: Throughout his career, Daniel Offen has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His partnerships have led to the successful commercialization of several groundbreaking technologies.

Conclusion: Daniel Offen's relentless passion for innovation and his commitment to pushing the boundaries of technology have solidified his reputation as a trailblazing inventor in the industry. His contributions continue to inspire future generations of inventors to think outside the box and create solutions that shape the world of tomorrow.

Profile summary based on public USPTO records.